20 employees
Exogenesis Corporation is engaged in developing and processing implantable vascular stents, orthopedic devices and other related products.
2005
$3.2M
from 2 investors over 2 rounds
Exogenesis Corporation raised $3.2M on December 1, 2010
Investors: Inflection Point Ventures and JDSU